AstraZeneca Revenue Hurt as Demand for COVID-19 Treatments Slumps; Stock Drops
AstraZeneca PLC missed Q4 profit forecasts as its revenue was slowed by falling demand for COVID-19 vaccines and medicines.
Source: investopedia.com
:max_bytes(150000):strip_icc()/AstraZeneca_Building_GettyImages-1240229036-e915fa2c7a3c4262bb31c69a724c6861.jpg)
Astrazeneca Adrs News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Astrazeneca Adrs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Astrazeneca Adrs Today - Breaking & Trending Today
AstraZeneca Is Getting Into the Weight-Loss Drug Game. The Stock Needs a Boost.
AstraZeneca has struck a licensing deal worth up to $2 billion for a weight-loss drug. Stockholders are welcoming the move as its shares have lagged peers...
Source: marketwatch.com
Daily Game Plan
TODAY’S GAME PLAN: from the trading desk, this is not research DATA/HEADLINES 8:30ET Chicago Fed Nat Activity Index; 10:30 Dallas Fed Manf. Activity: 6:00ET Fed's Kashkari speaks TODAY’S HIGHLIGHTS: Costco plans to offer members access to medical care through a deal with online marketplace SesameAsteroid chunks that may tell us about the earliest days of
Source: mrtopstep.com
AstraZeneca strikes $1 billion deal for Pfizer rare-disease gene therapies
Stock gains 5% after AstraZeneca's second-quarter results top analyst expectations.
Source: marketwatch.com
AstraZeneca Stock Is Sinking. A Cancer Drug Showed Disappointing Results.
American depositary receipts of AstraZeneca were falling Monday after the drugmaker reported disappointing results from a Phase 3 trial of a lung- cancer drug.
Source: marketwatch.com